Results 241 to 250 of about 17,175,483 (375)

AL Amyloidosis: Current Treatment and Outcomes. [PDF]

Adv Hematol
Locke M, Nieto M.
europepmc   +1 more source

Repetitive Transcranial Magnetic Stimulation Induces Cognitive Recovery in Alzheimer's Disease via GABAergic Neuron Activation of the Cx3cl1‐Cx3cr1 Axis

Cell Proliferation, EarlyView.
Schematic diagram illustrating the molecular mechanisms of the Cx3cl1‐Cx3cr1 axis mediated by rTMS activation of GABAergic neurons in the process of cognitive function recovery in AD. ABSTRACT This study aimed to investigate the impact of repetitive transcranial magnetic stimulation (rTMS) on cognitive recovery in Alzheimer's disease (AD) by exploring ...
Yunxiao Kang, Jilun Liu, Yu Wang, Jiaying Wang, Jinyang Wang, Chenming Zhou, Rui Cui, Tianyun Zhang   +7 more
wiley   +1 more source

Atypical Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis. [PDF]

Cureus
Faraci J, Connor JA, Randhawa S.
europepmc   +1 more source

Association between CMR‐derived hepatic T1‐time, tricuspid regurgitation and survival

European Journal of Clinical Investigation, EarlyView.
We investigated the association between tricuspid regurgitation (TR) severity and hepatic T1‐time in 1029 patients undergoing cardiac MRI and echocardiography. Hepatic T1‐time increased progressively with TR severity and remained independently associated after adjusting for NT‐proBNP and right ventricular function. Both TR and hepatic T1‐time predicted
Katharina Mascherbauer, Christina Kronberger, Manuel Gruber, Carolina Donà, Matthias Koschutnik, Varius Dannenberg, Michael Poledniczek, Laura Lunzer, Christian Nitsche, Franz Duca, Gregor Heitzinger, Kseniya Halavina, Dietrich Beitzke, Christian Loewe, Michael Trauner, Philipp Bartko, Julia Mascherbauer, Christian Hengstenberg, Andreas Kammerlander, Elisabeth Waldmann   +19 more
wiley   +1 more source

Rotational Mechanics of the Left Ventricle in AL Amyloidosis [PDF]

, 2010
Maria Cristina Porciani, Francesco Cappelli, Federico Perfetto, M Ciaccheri, Gabriele Castelli, Ilaria Ricceri, Marco Chiostri, Franco Bergesio, Luigi Padeletti   +8 more
openalex   +1 more source

Case report of isolated aortic valve AL-amyloidosis following aortic valve replacement. [PDF]

Eur Heart J Case Rep
Choudhury R, Jimenez-Zepeda VH, Mahe E, Fine NM.   +3 more
europepmc   +1 more source

Central nervous system involvement in cardiac amyloidosis: Redefining the heart‐brain axis

European Journal of Clinical Investigation, EarlyView.
Central nervous system involvement in cardiac amyloidosis. Amyloidosis is a systemic disease that can directly affect the central nervous system. Furthermore, the amyloid cardiomyopathy can indirectly affect the central nervous system by inducing systemic hypoperfusion and increasing the risk of acute ischaemic stroke.
Domenico Mario Giamundo, Giuliano Cassataro, Stefano Ministrini, Simon F. Stämpfli   +3 more
wiley   +1 more source

Long-term follow-up of patients with AL amyloidosis treated on a phase 1 trial of CAEL-101. [PDF]

Blood Adv
Hughes MS, Pan S, Chakraborty R, Raikhelkar J, Maurer MS, Mapara MY, Eisenberger A, Lentzsch S, Bhutani D.   +8 more
europepmc   +1 more source

From Trials to Practice: A 2025 Review of Idecabtagene Vicleucel and Ciltacabtagene Autoleucel Efficacy Across Clinical Studies and Real‐World Evidence

European Journal of Haematology, EarlyView.
ABSTRACT B‐cell maturation antigen (BCMA)‐directed chimeric antigen receptor (CAR) T‐cell therapies have revolutionized the approach and management of relapsed/refractory multiple myeloma (RRMM), and as of 2025, idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) are the only BCMA‐targeted CAR T‐cell therapies approved by the FDA.
Hector Garcia Pleitez, Sakditad Saowapa, Andrea Ortiz Maldonado, Chanakarn Kanitthamniyom, Diego Olavarria Bernal, Lukman Tijani   +5 more
wiley   +1 more source

Cystatin C as Biomarker for the Evaluation of Renal Outcome in AL Amyloidosis. [PDF]

Am J Hematol
Theodorakakou F, Fotiou D, Apostolakou F, Papassotiriou I, Spiliopoulou V, Ntanasis-Stathopoulos I, Malandrakis P, Migkou M, Kanellias N, Eleutherakis-Papaiakovou E, Psimenou E, Papanikolaou A, Gakiopoulou C, Marinaki S, Giannouli S, Gavriatopoulou M, Terpos E, Dimopoulos MA, Kastritis E.   +18 more
europepmc   +1 more source